BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Conditions:   Pulmonary Tuberculoses;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Rifafour e-275®;   Drug: Probe Drug Cocktail;   Drug: Dolutegravir 50mg Tab Sponsors:   Michael Hoelscher;   European and Developing Countries Clinical Trials Partnership (EDCTP);   Radboud University;   German Federal Ministry of Education and Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials